As no ETV6 specific inhibitor exists and given the recent interest in targeting apoptosis modulators in DLBCL [44], we evaluated the sensitivity our B-lymphoma cell lines to the BIRC5 inhibitor, YM155. The gene discussed is ETV6; the disease is diffuse large B-cell lymphoma.